These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Lin J, Kumari S, Kim C, Van TM, Wachsmuth L, Polykratis A, Pasparakis M. Nature; 2016 Dec 01; 540(7631):124-128. PubMed ID: 27819681 [Abstract] [Full Text] [Related]
6. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB. Suda J, Dara L, Yang L, Aghajan M, Song Y, Kaplowitz N, Liu ZX. J Immunol; 2016 Oct 15; 197(8):3120-3129. PubMed ID: 27605011 [Abstract] [Full Text] [Related]
7. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation. Wang Z, Feng J, Yu J, Chen G. J Cell Sci; 2019 May 20; 132(10):. PubMed ID: 31028177 [Abstract] [Full Text] [Related]
8. Phenytoin inhibits necroptosis. von Mässenhausen A, Tonnus W, Himmerkus N, Parmentier S, Saleh D, Rodriguez D, Ousingsawat J, Ang RL, Weinberg JM, Sanz AB, Ortiz A, Zierleyn A, Becker JU, Baratte B, Desban N, Bach S, Schiessl IM, Nogusa S, Balachandran S, Anders HJ, Ting AT, Bleich M, Degterev A, Kunzelmann K, Bornstein SR, Green DR, Hugo C, Linkermann A. Cell Death Dis; 2018 Mar 02; 9(3):359. PubMed ID: 29500402 [Abstract] [Full Text] [Related]
9. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Rickard JA, O'Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T, Vince JE, Lawlor KE, Ninnis RL, Anderton H, Hall C, Spall SK, Phesse TJ, Abud HE, Cengia LH, Corbin J, Mifsud S, Di Rago L, Metcalf D, Ernst M, Dewson G, Roberts AW, Alexander WS, Murphy JM, Ekert PG, Masters SL, Vaux DL, Croker BA, Gerlic M, Silke J. Cell; 2014 May 22; 157(5):1175-88. PubMed ID: 24813849 [Abstract] [Full Text] [Related]
10. Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Mulay SR, Desai J, Kumar SV, Eberhard JN, Thomasova D, Romoli S, Grigorescu M, Kulkarni OP, Popper B, Vielhauer V, Zuchtriegel G, Reichel C, Bräsen JH, Romagnani P, Bilyy R, Munoz LE, Herrmann M, Liapis H, Krautwald S, Linkermann A, Anders HJ. Nat Commun; 2016 Jan 28; 7():10274. PubMed ID: 26817517 [Abstract] [Full Text] [Related]
18. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Takahashi N, Vereecke L, Bertrand MJ, Duprez L, Berger SB, Divert T, Gonçalves A, Sze M, Gilbert B, Kourula S, Goossens V, Lefebvre S, Günther C, Becker C, Bertin J, Gough PJ, Declercq W, van Loo G, Vandenabeele P. Nature; 2014 Sep 04; 513(7516):95-9. PubMed ID: 25186904 [Abstract] [Full Text] [Related]
19. RIPK3 collaborates with GSDMD to drive tissue injury in lethal polymicrobial sepsis. Chen H, Li Y, Wu J, Li G, Tao X, Lai K, Yuan Y, Zhang X, Zou Z, Xu Y. Cell Death Differ; 2020 Sep 04; 27(9):2568-2585. PubMed ID: 32152555 [Abstract] [Full Text] [Related]
20. Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury. Martens S, Jeong M, Tonnus W, Feldmann F, Hofmans S, Goossens V, Takahashi N, Bräsen JH, Lee EW, Van der Veken P, Joossens J, Augustyns K, Fulda S, Linkermann A, Song J, Vandenabeele P. Cell Death Dis; 2017 Jun 29; 8(6):e2904. PubMed ID: 28661484 [Abstract] [Full Text] [Related] Page: [Next] [New Search]